$12.75 2%
PLRX Stock Price vs. AI Score (Last 150 days)
Data gathered: July 13

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Pliant Therapeutics

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States.


Pliant Therapeutics
Price $12.75
Target Price Sign up
Volume 826,530
Market Cap $754M
Year Range $10.52 - $19.59
Dividend Yield 0%
Revenue per Employee $41,032
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24015M-16M-47M-52M-0.780
Q4 '234.8M14M-14M-41M-47M-0.690
Q3 '23015M-16M-41M-48M-0.700
Q2 '23250,00015M-15M-41M-40M-0.700
Q1 '231M14M-13M-38M-37M-0.670

Insider Transactions View All

Ouimette Mike filed to sell 94,044 shares at $11.6.
July 12 '24
Hull Hans filed to sell 227,494 shares at $11.6.
July 12 '24
Coulie Bernard filed to sell 482,936 shares at $11.6.
July 12 '24
Cummings Keith Lamont filed to sell 282,115 shares at $11.6.
July 12 '24
Lefebvre Eric filed to sell 213,052 shares at $11.6.
July 12 '24

What is the Market Cap of Pliant Therapeutics?

The Market Cap of Pliant Therapeutics is $754M.

How Many People Work at Pliant Therapeutics?

As of our latest update, Pliant Therapeutics employed approximately 124 people worldwide. However, it's important to note that Pliant Therapeutics' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Pliant Therapeutics' revenue per employee?

$41,032. To calculate Pliant Therapeutics' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Pliant Therapeutics?

Currently, the price of one share of Pliant Therapeutics stock is $12.75.

How can I analyze the PLRX stock price chart for investment decisions?

The PLRX stock price chart above provides a comprehensive visual representation of Pliant Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Pliant Therapeutics shares. Our platform offers an up-to-date PLRX stock price chart, along with technical data analysis and alternative data insights.

Does PLRX offer dividends to its shareholders?

As of our latest update, Pliant Therapeutics (PLRX) does not offer dividends to its shareholders. Investors interested in Pliant Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Pliant Therapeutics?

Some of the similar stocks of Pliant Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.